Delta Global Management LP Lowers Holdings in The Cooper Companies, Inc. $COO

Delta Global Management LP trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 48.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,386 shares of the medical device company’s stock after selling 15,328 shares during the quarter. Delta Global Management LP’s holdings in Cooper Companies were worth $1,123,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Elevation Point Wealth Partners LLC raised its position in shares of Cooper Companies by 126.1% during the third quarter. Elevation Point Wealth Partners LLC now owns 9,510 shares of the medical device company’s stock valued at $652,000 after buying an additional 5,304 shares during the last quarter. Brevan Howard Capital Management LP bought a new position in shares of Cooper Companies during the third quarter worth $330,000. Clearline Capital LP grew its stake in Cooper Companies by 299.4% during the third quarter. Clearline Capital LP now owns 380,090 shares of the medical device company’s stock valued at $26,059,000 after acquiring an additional 284,921 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. increased its holdings in Cooper Companies by 72.8% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 19,127 shares of the medical device company’s stock valued at $1,302,000 after acquiring an additional 8,055 shares during the last quarter. Finally, Bank of America Corp DE lifted its stake in Cooper Companies by 3.0% in the 3rd quarter. Bank of America Corp DE now owns 1,941,503 shares of the medical device company’s stock worth $133,109,000 after purchasing an additional 56,973 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Cynthia L. Lucchese bought 1,784 shares of Cooper Companies stock in a transaction dated Monday, December 22nd. The shares were acquired at an average price of $84.06 per share, with a total value of $149,963.04. Following the completion of the purchase, the director owned 9,445 shares in the company, valued at $793,946.70. The trade was a 23.29% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Maria Rivas bought 1,000 shares of the stock in a transaction dated Thursday, December 18th. The stock was purchased at an average price of $82.13 per share, with a total value of $82,130.00. Following the acquisition, the director directly owned 11,141 shares in the company, valued at approximately $915,010.33. The trade was a 9.86% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have bought 4,784 shares of company stock valued at $397,093. 2.08% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have commented on COO. William Blair raised shares of Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. Robert W. Baird boosted their target price on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research report on Friday, December 5th. Needham & Company LLC raised their price target on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a report on Friday, March 6th. JPMorgan Chase & Co. upped their price objective on Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a report on Friday, December 5th. Finally, Mizuho set a $100.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a report on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Price Performance

NASDAQ:COO opened at $71.04 on Tuesday. The firm has a market capitalization of $13.86 billion, a price-to-earnings ratio of 35.17, a PEG ratio of 1.80 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The business has a 50 day simple moving average of $80.99 and a 200-day simple moving average of $76.01. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.